A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophsophamide + dactinomycin in patients with good-prognosis germ cell tumors

Journal of Clinical Oncology

Volumn 6, Issue 8, 1988, Pages 1231-1238

  Bosl, G J ^a   Geller, N L ^a   Bajorin, D ^a   Leitner, S P ^a   Yagoda, A ^a   Golbey, R B ^a   Scher, H ^a   Vogelzang, N J ^a   Auman, J ^a   Carey, R ^a   Fair, W R ^a   Herr, H ^a   Morse, M ^a   Sogani, P ^a   Whitmore Jr , W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; VINBLASTINE;

ADOLESCENT; ADULT; CLINICAL TRIAL; CONTROLLED STUDY; GERM CELL TUMOR; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0023684525     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1988.6.8.1231     Document Type: Article

References (0)